{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:41:50Z","timestamp":1790930510979,"version":"4.1.0"},"reference-count":34,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,1,1]]},"abstract":"\n Objective.<\/jats:title>\n The aim of this study was to define the role of possible risk factors for the development of cystic fibrosis (CF)-related liver disease and to analyze the association between liver disease and the different genotypes present in the Israeli CF patient population.<\/jats:p>\n <\/jats:sec>\n \n Patients and Methods.<\/jats:title>\n All patients followed at the seven CF centers in Israel were included in this study. Liver disease was determined by persistently elevated serum liver enzymes and\/or bilirubin, and\/or significant ultrasonographic changes suggestive of chronic liver disease. The following clinical parameters were evaluated: ethnic origin, age at assessment of liver function, sex, history of meconium ileus, pancreatic function, history of distal intestinal obstruction syndrome, pulmonary function, and cystic fibrosis transmembrane conductance regulator mutation analysis.<\/jats:p>\n <\/jats:sec>\n \n Results.<\/jats:title>\n Of the 288 patients screened, 80 (28%) had liver disease. Of the 256 patients with pancreatic insufficiency, 80 (31%) had liver disease compared with none of the 32 patients with pancreatic sufficiency. Genotype-phenotype correlation was performed on 207 patients carrying identified mutations that were previously classified according to phenotype severity. Liver disease was found in 56 (32%) of 173 patients carrying mutations associated with a severe phenotype and in 6 (38%) of 16 patients carrying at least one mutation associated with a variable genotype (G85E and\/or 5T allele). None of the 18 patients carrying the 3849+10kb C-&gt;T mutation had liver disease. Prevalence of liver disease increased with age. No correlation was found between liver disease and severity of lung disease, nutritional status, history of meconium ileus, or distal intestinal obstruction syndrome.<\/jats:p>\n <\/jats:sec>\n \n Conclusion.<\/jats:title>\n CF patients who have pancreatic insufficiency and carry mutations associated with a severe or a variable genotype are at increased risk to develop liver disease.<\/jats:p>\n <\/jats:sec>","DOI":"10.1542\/peds.103.1.52","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:45:45Z","timestamp":1092440745000},"page":"52-57","source":"Crossref","is-referenced-by-count":99,"title":["Clinical and Genetic Risk Factors for Cystic Fibrosis-related Liver Disease"],"prefix":"10.1542","volume":"103","author":[{"given":"Michael","family":"Wilschanski","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, Cystic Fibrosis Center, Shaare Zedek Medical Center, Hebrew University, Jerusalem;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Rivlin","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Center, Carmel Medical Center, Haifa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Cohen","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Cystic Fibrosis Center, Shaare Zedek Medical Center, Hebrew University, Jerusalem;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arieh","family":"Augarten","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Center, Sheba Medical Center, Tel Hashomer;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Blau","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Center, Schneider Children's Medical Center, Petah Tikva;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha","family":"Aviram","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Center, Soroka Medical Center, Ben Gurion University, Beer Sheba;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Bentur","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Center, Rambam Medical Center, Haifa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim","family":"Springer","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Center, Hadassah University Hospital, Jerusalem;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Vila","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Ichilov Medical Center, Tel Aviv; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Branski","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Cystic Fibrosis Center, Shaare Zedek Medical Center, Hebrew University, Jerusalem;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batsheva","family":"Kerem","sequence":"additional","affiliation":[{"name":"Department of Genetics, Life Sciences Institute, Hebrew University, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Kerem","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Cystic Fibrosis Center, Shaare Zedek Medical Center, Hebrew University, Jerusalem;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[1999,1,1]]},"reference":[{"key":"2021121019342518600_B1"},{"key":"2021121019342518600_B2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: genetic analysis.","volume":"245","author":"Kerem","year":"1989","journal-title":"Science."},{"key":"2021121019342518600_B3","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM199011293232203","article-title":"The relationship between genotype and phenotype in cystic fibrosis: analysis of the most common mutation \u25b5F508).","volume":"323","author":"Kerem","year":"1990","journal-title":"N Engl J Med."},{"key":"2021121019342518600_B4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/humu.1380040302","article-title":"Population variations of common cystic fibrosis mutations.","volume":"4","author":"Cystic Fibrosis Genetic Analysis Consortium","year":"1994","journal-title":"Hum Mutat"},{"key":"2021121019342518600_B5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1056\/NEJM199310283291804","article-title":"Correlation between genotype and phenotype in patients with cystic fibrosis.","volume":"329","author":"Cystic Fibrosis Genotype-Phenotype Consortium","year":"1993","journal-title":"N Engl J Med"},{"key":"2021121019342518600_B6","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1164\/ajrccm.155.6.9196095","article-title":"A CFTR splice variant with partial penetrance associated with variable cystic fibrosis presentation.","volume":"155","author":"Kerem","year":"1997","journal-title":"Am J Respir Crit Care Med."},{"key":"2021121019342518600_B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.100.3.e5","article-title":"A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype.","volume":"100","author":"Kerem","year":"1997","journal-title":"Pediatrics."},{"key":"2021121019342518600_B8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0022-3476(94)70361-2","article-title":"Analysis of risk factors for the development of liver disease in CF.","volume":"124","author":"Colombo","year":"1994","journal-title":"J Pediatr."},{"key":"2021121019342518600_B9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00005176-198212000-00005","article-title":"Hepatobiliary disease in cystic fibrosis: survey of current issues and concepts.","volume":"1","author":"Roy","year":"1982","journal-title":"J Pediatr Gastoenterol Nutr."},{"key":"2021121019342518600_B10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/adc.66.6.698","article-title":"Prevalence of liver disease in cystic fibrosis.","volume":"66","author":"Scott-Jupp","year":"1991","journal-title":"Arch Dis Child."},{"key":"2021121019342518600_B11"},{"key":"2021121019342518600_B12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-2007-1007316","article-title":"Hepatobiliary disease in cystic fibrosis.","volume":"14","author":"Colombo","year":"1994","journal-title":"Semin Liver Dis."},{"key":"2021121019342518600_B13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1542\/peds.18.3.387","article-title":"A distinctive type of biliary cirrhosis of the liver associated with cystic fibrosis of the pancreas.","volume":"188","author":"Di Sant' Agnese","year":"1956","journal-title":"Pediatrics."},{"key":"2021121019342518600_B14","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.1840150418","article-title":"Genotype analysis of DF508, G551D, R553X mutations in children and adults with cystic fibrosis with and without liver disease.","volume":"15","author":"Duthie","year":"1992","journal-title":"Hepatology."},{"key":"2021121019342518600_B15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/gte.1997.1.35","article-title":"Cystic fibrosis in Jews: frequency and mutation distribution.","volume":"1","author":"Kerem","year":"1997","journal-title":"Genet Testing."},{"key":"2021121019342518600_B16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00207378","article-title":"Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel.","volume":"96","author":"Kerem","year":"1995","journal-title":"Hum Genet."},{"key":"2021121019342518600_B17"},{"key":"2021121019342518600_B18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/adc.41.219.454","article-title":"Standards from birth to maturity for height, weight, height velocity and weight velocity: British children, 1965.","volume":"41","author":"Tanner","year":"1966","journal-title":"Arch Dis Child."},{"key":"2021121019342518600_B19","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199410133311503","article-title":"A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.","volume":"331","author":"Highsmith","year":"1994","journal-title":"N Engl J Med."},{"key":"2021121019342518600_B20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0140-6736(93)91885-P","article-title":"Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849+10kb C->T mutation.","volume":"342","author":"Augarten","year":"1993","journal-title":"Lancet."},{"key":"2021121019342518600_B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3476(05)83478-X","article-title":"The changing epidemiology of cystic fibrosis.","volume":"122","author":"FitzSimmons","year":"1993","journal-title":"J Pediatr."},{"key":"2021121019342518600_B22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hep.510230213","article-title":"The role of hepatic scintigraphy in cystic fibrosis.","volume":"23","author":"O'Connor","year":"1996","journal-title":"Hepatology."},{"key":"2021121019342518600_B23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.1840150421","article-title":"Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease.","volume":"15","author":"Colombo","year":"1992","journal-title":"Hepatology."},{"key":"2021121019342518600_B24","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1056\/NEJM199705293362217","article-title":"Prediction of liver fibrosis according to serum collagen VI level in children with cystic fibrosis.","volume":"336","author":"Gerling","year":"1997","journal-title":"N Engl J Med."},{"key":"2021121019342518600_B25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005176-198909010-00004","article-title":"Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: an autopsy study in cystic fibrosis.","volume":"9","author":"Maurage","year":"1989","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"2021121019342518600_B26","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1164\/ajrccm.154.5.8912731","article-title":"Cystic fibrosis.","volume":"154","author":"Davis","year":"1996","journal-title":"Am J Respir Crit Care Med."},{"key":"2021121019342518600_B27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ng0396-280","article-title":"Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor.","volume":"12","author":"Rozmahel","year":"1996","journal-title":"Nature Genet."},{"key":"2021121019342518600_B28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1006\/bbrc.1996.0306","article-title":"In vivo measurements of ion transport in long-living CF mice.","volume":"219","author":"Wilschanski","year":"1996","journal-title":"Biochem Biophys Res Comm."},{"key":"2021121019342518600_B29","first-page":"87","article-title":"The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.","volume":"60","author":"Rave-Harel","year":"1997","journal-title":"Am J Hum Genet."},{"key":"2021121019342518600_B30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF00197165","article-title":"Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene.","volume":"87","author":"Dork","year":"1991","journal-title":"Hum Genet."},{"key":"2021121019342518600_B31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ng1193-274","article-title":"A mutation in CFTR produces different phenotypes depending on chromosomal background.","volume":"5","author":"Kiesewetter","year":"1993","journal-title":"Nature Genet."},{"key":"2021121019342518600_B32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0022-3476(05)81103-5","article-title":"Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.","volume":"117","author":"Colombo","year":"1990","journal-title":"J Pediatr."},{"key":"2021121019342518600_B33","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/gut.31.8.918","article-title":"Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis.","volume":"31","author":"Cotting","year":"1990","journal-title":"Gut."},{"key":"2021121019342518600_B34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-3476(05)82561-2","article-title":"Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis.","volume":"121","author":"Galabert","year":"1992","journal-title":"J Pediatr."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/103\/1\/52\/840501\/52.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/103\/1\/52\/840501\/52.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T05:53:51Z","timestamp":1639202031000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/103\/1\/52\/62088\/Clinical-and-Genetic-Risk-Factors-for-Cystic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1999,1,1]]},"published-print":{"date-parts":[[1999,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.103.1.52","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[1999,1,1]]}}}